Tuesday, August 9, 2016

BRIEF-Repros Therapeutics Inc. reported Q2 EPS ($0.18)

* Repros Therapeutics Inc. reports second quarter 2016

financial results

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)